Search research articles
Contact Us
Filters
Showing results (61-70 of 133) with videos related to
Page
of 14
Sort By:
Journal of Medical Economics
|
July 21, 2025
Clinical characteristics, healthcare resource use, and survival outcomes among patients with advanced NSCLC tested for KRAS mutations in France, the United Kingdom, and Switzerland
Marie Wislez, Andromachi Giannopoulou, Isabelle Borget, et al.
International Journal of Technology Assessment in Health Care
|
September 21, 2023
Hospital-based health technology assessment of innovative medical devices: insights from a nationwide survey in France
Tess Martin, Alessandra Guercio, Hélène Besseau, et al.
Thyroid : Official Journal of the American Thyroid Association
|
December 6, 2011
Thyroid cancer patients treated with 131I: radiation dose to relatives after discharge from the hospital
Hervé Rémy, Jérémy Coulot, Isabelle Borget, et al.
Plos One
|
January 24, 2025
Healthcare resource utilization and costs in immunodeficient patients receiving subcutaneous Ig: Real-world evidence from France
Guillaume Lefèvre, Isabelle Borget, Cinira Lefèvre, et al.
Frontiers in Oncology
|
October 7, 2015
Dosimetric Effects of the Interfraction Variations during Whole Breast Radiotherapy: A Prospective Study
Julian Jacob, Steve Heymann, Isabelle Borget, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 2, 2013
Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study
Marie-Hélène Massicotte, Isabelle Borget, Sophie Broutin, et al.
Frontiers in Oncology
|
June 10, 2022
Robot-Assisted Surgery vs Robotic Stereotactic Body Radiotherapy in Prostate Cancer: A Cost-Utility Analysis
Line Farah, Nicolas Magne, Nicolas Martelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 23, 2021
RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancer
Désirée Deandreis, Aline Maillard, Slimane Zerdoud, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology
|
February 27, 2022
Economic evaluation of Medically Assisted Reproduction: An educational overview of methods and applications for healthcare professionals
Jeroen Luyten, Mark P Connolly, Evelyn Verbeke, et al.
Advances in Therapy
|
October 9, 2025
Efficiency of Gla-300 versus Gla-100 Across Age Groups in People Living with Type 2 Diabetes in France: A Post Hoc Analysis of an Observational Longitudinal Study
Patrice Darmon, Olivier Hanon, Pierre Gourdy, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 133) with videos related to
Sort By:
Page
of 14
Journal of Medical Economics
|
July 21, 2025
Clinical characteristics, healthcare resource use, and survival outcomes among patients with advanced NSCLC tested for KRAS mutations in France, the United Kingdom, and Switzerland
Marie Wislez, Andromachi Giannopoulou, Isabelle Borget, et al.
International Journal of Technology Assessment in Health Care
|
September 21, 2023
Hospital-based health technology assessment of innovative medical devices: insights from a nationwide survey in France
Tess Martin, Alessandra Guercio, Hélène Besseau, et al.
Thyroid : Official Journal of the American Thyroid Association
|
December 6, 2011
Thyroid cancer patients treated with 131I: radiation dose to relatives after discharge from the hospital
Hervé Rémy, Jérémy Coulot, Isabelle Borget, et al.
Plos One
|
January 24, 2025
Healthcare resource utilization and costs in immunodeficient patients receiving subcutaneous Ig: Real-world evidence from France
Guillaume Lefèvre, Isabelle Borget, Cinira Lefèvre, et al.
Frontiers in Oncology
|
October 7, 2015
Dosimetric Effects of the Interfraction Variations during Whole Breast Radiotherapy: A Prospective Study
Julian Jacob, Steve Heymann, Isabelle Borget, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 2, 2013
Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study
Marie-Hélène Massicotte, Isabelle Borget, Sophie Broutin, et al.
Frontiers in Oncology
|
June 10, 2022
Robot-Assisted Surgery vs Robotic Stereotactic Body Radiotherapy in Prostate Cancer: A Cost-Utility Analysis
Line Farah, Nicolas Magne, Nicolas Martelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 23, 2021
RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancer
Désirée Deandreis, Aline Maillard, Slimane Zerdoud, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology
|
February 27, 2022
Economic evaluation of Medically Assisted Reproduction: An educational overview of methods and applications for healthcare professionals
Jeroen Luyten, Mark P Connolly, Evelyn Verbeke, et al.
Advances in Therapy
|
October 9, 2025
Efficiency of Gla-300 versus Gla-100 Across Age Groups in People Living with Type 2 Diabetes in France: A Post Hoc Analysis of an Observational Longitudinal Study
Patrice Darmon, Olivier Hanon, Pierre Gourdy, et al.
Page
of 14